Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 29,713	$ 52,670
Accounts receivable, net of allowances of $239 and $275	11,274	10,098
Inventory	11,558	12,781
Prepaid expenses and other current assets	3,503	2,522
Total current assets	56,048	78,071
Property and equipment, net	2,213	2,341
Intangible assets, net	1,454	1,739
Right-of-use assets	1,560	1,738
Other long-term assets		2,276
Deferred tax asset, net	62	140
Restricted cash	250	265
Total assets	61,587	86,570
Current liabilities:
Accounts payable	2,373	2,147
Accrued expenses and other current liabilities	14,604	13,451
Total current liabilities	16,977	15,598
Longterm debt	41,494	41,124
Other longterm liabilities	1,559	1,390
Total liabilities	60,030	58,112
Stockholders' equity:
Preferred stock; $0.001 par value: 10,000,000 shares authorized; no shares issued and outstanding
Common stock; $0.001 par value: 200,000,000 shares authorized; 40,341,535 and 39,395,712 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively	40	39
Additional paid-in capital	389,946	387,059
Accumulated other comprehensive income	91	90
Accumulated deficit	(388,520)	(358,730)
Total stockholders' equity	1,557	28,458
Total liabilities and stockholders' equity	$ 61,587	$ 86,570